V. Shankaran

Journal of Clinical Investigation · 2016–2018

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom V. Shankaran trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Peter C. Austin (in Statistics and Probability)

Papers from V. Shankaran's perspective

Ordered by how strongly the researchers V. Shankaran trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Observational Studies
  2. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
  3. Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells (Science Translational Medicine)
  4. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. (The Oncologist)
  5. Washington Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (Health Affairs)
  6. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients (Nature)
  7. PD-1 blockade induces responses by inhibiting adaptive immune resistance (Nature)
  8. The future of immune checkpoint therapy (Science)
  9. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity (Nature)
  10. Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma (New England Journal of Medicine)

Their papers